Aspen Aerogels (ASPN) Tops Q4 EPS by 10c, offers outlook

Aspen Aerogels (NYSE: ASPN) reported Q4 EPS of ($0.01), $0.10 better than the analyst estimate of ($0.11). Revenue for the quarter came in at $84.22 million versus the consensus estimate of $80.85 million.

2024 Financial Outlook

Aspen issues its 2024 full year outlook as follows:

Total revenue is expected to be at least $350 million, with approximately $150 million in Energy Industrial revenues, and $200 million in Thermal Barrier revenues
Adjusted EBITDA is expected to be at least $30 million
Net loss is expected to be under $23 million
Net loss per share is expected to be under $0.30
Capital Expenditures, excluding investments in Plant II, are expected to be $50 million
Capital Expenditures for Plant II in the first half of 2024 are expected to be $30 million, with an additional $15 million for the second half of 2024, assuming continued construction right-timing

The Company\'s 2024 outlook assumes depreciation and amortization of $30 million, stock-based compensation expense of $14 million, interest expense of $9 million and weighted average shares outstanding of 76.5 million for the full year.

For earnings history and earnings-related data on Aspen Aerogels (ASPN) click here.

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• UBS Reiterates Neutral Rating on Clorox (CLX) as External Challenges Persist
• Nvidia pitches Vera CPU to Chinese clients with August delivery target